期刊文献+

盐酸氯卡色林有关物质的合成

Synthesis of the Related Substances of Lorcaserin Hydrochloride
原文传递
导出
摘要 为控制盐酸氯卡色林的质量,制备了5个有关物质:8-氯-3-(2-氯丙基)-1-甲基-2,3,4,5-四氢-1H-苯并氮杂䓬(A)、(R)-8-氯-1-甲基-3-乙酰基-1,2,4,5-四氢-1H-苯并氮杂䓬(B)、(S)-8-氯-1-甲基-2,3,4,5-四氢-1H-苯并氮杂䓬(2S,3S)-2,3-二羟基丁二酸盐(2∶1)(C)、(R)-7-氯-1-甲基-2,3,4,5-四氢-1H-苯并氮杂䓬盐酸盐(D)、(S)-7-氯-1-甲基-2,3,4,5-四氢-1H-苯并氮杂䓬盐酸盐(E)。其中有关物质A、D和E未见文献报道。产物结构均经1H NMR和MS确证,且有关物质D中氯原子的位置和手性构型经单晶X射线衍射确证,可作为盐酸氯卡色林质量研究的对照物。 To perform the quality control of lorcaserin hydrochloride,five related substances were prepared.These substances were 8-chloro-3-(2-chloropropyl)-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine(A),(R)-8-chloro-1-methyl-3-acetyl-1,2,4,5-tetrahydro-1H-benzo[d]azepine(B),(S)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]-azepine(2S,3S)-2,3-dihydroxysuccinate(2∶1)(C),(R)-7-chloro-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine hydrochloride(D),(S)-7-chloro-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine hydrochloride(E).The related substances A,D and E have not been reported in literature.The structures of the above related substances were confirmed by 1H NMR and MS,and the substitution position of chlorine atom as well as chiral configuration of related substance D was confirmed by single crystal X-ray diffraction,which could be used as references of lorcaserin hydrochloride quality control.
作者 汤君 何广卫 张强 王奎 刘为中 刘资进 TANG Jun;HE Guangwei;ZHANG Qiang;WANG Kui;LIU Weizhong;LIU Zijin(Hefei Industrial Pharmaceutical Institute Co.,Ltd.,Hefei 230601;School of Pharmacy,Anhui University of Chinese Medicine,Hefei 230012)
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2022年第2期196-201,共6页 Chinese Journal of Pharmaceuticals
关键词 盐酸氯卡色林 激酶抑制剂 有关物质 合成 lorcaserin hydrochloride kinase inhibitor related substance synthesis
  • 相关文献

参考文献3

二级参考文献6

  • 1BURBAUM B W, GILSON III C A, AYTES S, et al. Processes for preparing 3-benzazepines:WO, 2005019179 A2[P]. 2005-03-03.
  • 2BAI B, WANG Y. The use of lorcaserin in the management of obesity: a critical appraisal[J]. Drug Des Dev Ther, 2011, 5: 1-7.
  • 3BAYS H E. Lorcaserin: drug profile and illustrative model of the regulatory challenges of weight-loss drug development[J]. ERCT, 2011, 9(3): 265-277.
  • 4WEIGL U, PORSTMANN F, STRAESSLER C, et al. Processes for preparation of 8-chloro-1-methyl-2,3,4,5- tetrahydro-1H-3-benzazepine and intermediates.:WO, 2007120517 A2[P]. 2007-10-25.
  • 5钟杭,赵临襄.绿卡色林[J].中国药物化学杂志,2012,22(6):543-543. 被引量:4
  • 6石卫峰,归成,李晓宇,刘皋林.治疗肥胖的新药氯卡色林[J].中国新药杂志,2014,23(2):127-129. 被引量:6

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部